Imagine tossing and turning all night, not because of a noisy neighbor or an uncomfortable bed, but because of the relentless itch and emotional toll of a skin condition. This is the reality for millions of adults with atopic dermatitis (AD), a chronic skin disease that goes beyond physical discomfort. But here's where it gets controversial: a groundbreaking Korean study published in Scientific Reports (https://www.nature.com/articles/s41598-025-26798-0#Abs1) suggests it’s not the skin condition itself that steals their sleep—it’s the stress it causes. And this is the part most people miss: stress alone could explain why those with AD sleep less, even if the effect seems small for individuals.
AD, characterized by itchy, dry, and inflamed skin, affects a staggering number of people worldwide. As of 2023, approximately 101.27 million adults and 102.78 million children were living with this condition. In South Korea alone, about 1.5 million people were diagnosed with AD in 2019 (https://anndermatol.org/DOIx.php?id=10.5021/ad.22.038), though comprehensive data for the entire country remains limited. Beyond the physical symptoms, AD can disrupt daily life, from sleep disturbances to emotional stress, including anxiety, frustration, and social pressure due to visible skin symptoms.
Previous studies have consistently shown that individuals with AD tend to sleep less than those without it. However, researchers have long debated whether the skin condition itself is the culprit or if stress and other psychological factors play a more significant role. To shed light on this, a Korean research team from institutions like the Jaseng Spine and Joint Research Institute and Woosuk University’s College of Korean Medicine analyzed data from over 64,900 adults aged 19 and older, sourced from the Korea National Health and Nutrition Examination Survey (2007–2018).
Participants self-reported their AD diagnosis, daily stress levels, and average sleep hours. Using statistical models, the researchers tested two key questions: Does AD directly lead to less sleep? And does stress mediate the relationship between AD and sleep? The findings were eye-opening. While AD itself wasn’t strongly linked to shorter sleep, stress emerged as a critical factor. Adults with AD reported higher stress levels, and this stress was strongly associated with reduced sleep. In fact, stress accounted for about 25% of the sleep difference between those with and without AD.
This study’s strength lies in its massive scale and its use of mediation analysis, which revealed that stress acts as an intermediary between AD and sleep, rather than assuming a direct cause-and-effect relationship. However, it’s not without limitations. The data was cross-sectional, meaning it couldn’t prove causation. Self-reported measures like stress levels and sleep hours may also introduce bias. Additionally, the study didn’t assess AD severity or sleep quality metrics like nighttime awakenings.
So, what does this mean for the millions living with AD? The authors suggest that managing stress could be a game-changer. Techniques like counseling, mindfulness, or other stress-reduction methods might not only improve sleep but also enhance overall quality of life. But here’s a thought-provoking question: If stress is such a significant factor, should healthcare providers focus more on mental health interventions for AD patients? Let’s discuss—do you think stress management should be a priority in treating AD, or is the focus better placed on managing skin symptoms? Share your thoughts in the comments below!
